Kah Poh Loh1, Mostafa R Mohamed1, Sindhuja Kadambi1, Eva Culakova2, Huiwen Xu2, Allison Magnuson1, Marie Flannery3, Paul R Duberstein4, Ronald M Epstein1,5,6, Colin McHugh1, Ryan D Nipp7, Kelly M Trevino8, Chandrika Sanapala1, Bianca A Hall1, Beverly Canin9, Arlene A Gayle10, Alison Conlin11, James Bearden12, Supriya G Mohile1. 1. James P Wilmot Cancer Institute, Division of Hematology/Oncology, Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA. 2. Department of Surgery, Cancer Control, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA. 3. School of Nursing, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA. 4. Department of Health Behavior, Society, and Policy, Rutgers School of Public Health, Piscataway, New Jersey, USA. 5. Department of Family Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA. 6. Department of Medicine, Palliative Care, University of Rochester Medical Center, Rochester, New York, USA. 7. Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA. 8. Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, New York, USA. 9. SCOREboard Advisory Group, University of Rochester Medical Center, Rochester, New York, USA. 10. Wisconsin National Cancer Institute (NCI) Community Oncology Research Program, Wisconsin, USA. 11. Pacific Cancer Research Consortium NCI Community Oncology Research Program, Washington, USA. 12. Southeast Clinical Oncology Research Consortium, Winston-Salem, North Carolina, USA.
Abstract
BACKGROUND: Caregivers of adults with cancer often report a different understanding of the patient's prognosis than the oncologist. We examine the associations of caregiver-oncologist prognostic concordance with caregiver depressive symptoms, distress, and quality of life (QoL). We also explore whether these relationships differed by caregiver environment mastery, an individual's sense of control, and effectiveness in managing life situations. MATERIALS AND METHODS: We used data from a national geriatric assessment cluster-randomized trial (URCC 13070) that recruited patients aged 70 years and older with incurable cancer considering any line of cancer treatment at community oncology practices, their caregivers, and their oncologists. At enrollment, caregivers and oncologists estimated the patient's prognosis (0-6 months, 7-12 months, 1-2 years, 2-5 years, and >5 years; identical responses were concordant). Caregivers completed the Ryff's environmental mastery at enrollment. At 4-6 weeks, caregivers completed the Patient Health Questionnaire-2 (depressive symptoms), distress thermometer, and 12-Item Short-Form Health Survey (quality of life [QoL]). We used generalized estimating equations in models adjusted for covariates. We then assessed the moderation effect of caregiver mastery. RESULTS: Of 411 caregiver-oncologist dyads (mean age = 66.5 years), 369 provided responses and 28% were concordant. Prognostic concordance was associated with greater caregiver depressive symptoms (β = 0.30; p = .04) but not distress or QoL. A significant moderation effect for caregiver depressive symptoms was found between concordance and mastery (p = .01). Specifically, among caregivers with low mastery (below median), concordance was associated with greater depressive symptoms (β = 0.68; p = .003). CONCLUSIONS: Caregiver-oncologist prognostic concordance was associated with caregiver depressive symptoms. We found a novel moderating effect of caregiver mastery on the relationship between concordance and caregiver depressive symptoms. IMPLICATIONS FOR PRACTICE: Caregiver-oncologist prognostic concordance is associated with greater caregiver depressive symptoms, particularly in those with low caregiver mastery. When discussing prognosis with caregivers, physicians should be aware that prognostic understanding may affect caregiver psychological health and should assess their depressive symptoms. In addition, while promoting accurate prognostic understanding, physicians should also identify strengths and build resilience among caregivers.
BACKGROUND: Caregivers of adults with cancer often report a different understanding of the patient's prognosis than the oncologist. We examine the associations of caregiver-oncologist prognostic concordance with caregiver depressive symptoms, distress, and quality of life (QoL). We also explore whether these relationships differed by caregiver environment mastery, an individual's sense of control, and effectiveness in managing life situations. MATERIALS AND METHODS: We used data from a national geriatric assessment cluster-randomized trial (URCC 13070) that recruited patients aged 70 years and older with incurable cancer considering any line of cancer treatment at community oncology practices, their caregivers, and their oncologists. At enrollment, caregivers and oncologists estimated the patient's prognosis (0-6 months, 7-12 months, 1-2 years, 2-5 years, and >5 years; identical responses were concordant). Caregivers completed the Ryff's environmental mastery at enrollment. At 4-6 weeks, caregivers completed the Patient Health Questionnaire-2 (depressive symptoms), distress thermometer, and 12-Item Short-Form Health Survey (quality of life [QoL]). We used generalized estimating equations in models adjusted for covariates. We then assessed the moderation effect of caregiver mastery. RESULTS: Of 411 caregiver-oncologist dyads (mean age = 66.5 years), 369 provided responses and 28% were concordant. Prognostic concordance was associated with greater caregiver depressive symptoms (β = 0.30; p = .04) but not distress or QoL. A significant moderation effect for caregiver depressive symptoms was found between concordance and mastery (p = .01). Specifically, among caregivers with low mastery (below median), concordance was associated with greater depressive symptoms (β = 0.68; p = .003). CONCLUSIONS: Caregiver-oncologist prognostic concordance was associated with caregiver depressive symptoms. We found a novel moderating effect of caregiver mastery on the relationship between concordance and caregiver depressive symptoms. IMPLICATIONS FOR PRACTICE: Caregiver-oncologist prognostic concordance is associated with greater caregiver depressive symptoms, particularly in those with low caregiver mastery. When discussing prognosis with caregivers, physicians should be aware that prognostic understanding may affect caregiver psychological health and should assess their depressive symptoms. In addition, while promoting accurate prognostic understanding, physicians should also identify strengths and build resilience among caregivers.
Authors: Joseph A Greer; Jamie M Jacobs; Areej El-Jawahri; Ryan D Nipp; Emily R Gallagher; William F Pirl; Elyse R Park; Alona Muzikansky; Juliet C Jacobsen; Vicki A Jackson; Jennifer S Temel Journal: J Clin Oncol Date: 2017-11-15 Impact factor: 44.544
Authors: Kirti Malhotra; Joshua J Fenton; Paul R Duberstein; Ronald M Epstein; Guibo Xing; Daniel J Tancredi; Michael Hoerger; Robert Gramling; Richard L Kravitz Journal: Cancer Date: 2019-04-29 Impact factor: 6.860
Authors: Annelies Janssens; Sofia Derijcke; Daniëlle Galdermans; Marc Daenen; Veerle Surmont; Els De Droogh; Anneke Lefebure; Erika Saenen; Elke Vandenbroucke; Ann-Marie Morel; Anna Sadowska; Jan P van Meerbeeck Journal: Clin Lung Cancer Date: 2018-12-13 Impact factor: 4.785
Authors: A El-Jawahri; L Traeger; K Kuzmuk; J Eusebio; H Vandusen; T Keenan; J Shin; E R Gallagher; J A Greer; W F Pirl; V A Jackson; K K Ballen; T R Spitzer; T A Graubert; S McAfee; B Dey; Y-B A Chen; J S Temel Journal: Bone Marrow Transplant Date: 2015-05-11 Impact factor: 5.483
Authors: Kah Poh Loh; Huiwen Xu; Ronald M Epstein; Supriya G Mohile; Holly G Prigerson; Sandra Plumb; Susan Ladwig; Sindhuja Kadambi; Melisa L Wong; Colin McHugh; Amy An; Kelly Trevino; Fahad Saeed; Paul R Duberstein Journal: J Pain Symptom Manage Date: 2020-02-13 Impact factor: 5.576
Authors: Nikesha Gilmore; Huiwen Xu; Lee Kehoe; Amber S Kleckner; Kiran Moorthi; Lianlian Lei; Mostafa R S Mohamed; Kah Poh Loh; Eva Culakova; Marie Flannery; Erika Ramsdale; Paul R Duberstein; Beverly Canin; Charles Kamen; Gilbert Giri; Erin Watson; Amita Patil; Adedayo A Onitilo; Brian Burnette; Michelle Janelsins; Supriya G Mohile Journal: Cancer Date: 2021-11-11 Impact factor: 6.921
Authors: Kah Poh Loh; Erin Watson; Eva Culakova; Marie Flannery; Michael Sohn; Huiwen Xu; Sindhuja Kadambi; Allison Magnuson; Colin McHugh; Chandrika Sanapala; Lee Kehoe; Victor G Vogel; Brian L Burnette; Vincent Vinciguerra; Supriya G Mohile; Paul R Duberstein Journal: J Geriatr Oncol Date: 2022-03-08 Impact factor: 3.929
Authors: Kah Poh Loh; Christopher L Seplaki; Chandrika Sanapala; Reza Yousefi-Nooraie; Jennifer L Lund; Ronald M Epstein; Paul R Duberstein; Marie Flannery; Eva Culakova; Huiwen Xu; Colin McHugh; Heidi D Klepin; Po-Ju Lin; Erin Watson; Valerie Aarne Grossman; Jane Jijun Liu; Jodi Geer; Mark A O'Rourke; Karen Mustian; Supriya G Mohile Journal: JAMA Netw Open Date: 2022-02-01
Authors: Gina Tuch; Chandrika Sanapala; Supriya G Mohile; Paul R Duberstein; Enrique Soto-Perez-de-Celis; Huiwen Xu; Eva Culakova; Marie Flannery; Reza Yousefi-Nooraie; Ronald M Epstein; Colin McHugh; Valerie Aarne; Hannah Kim; Jodi Geer; Mark A O'Rourke; Nicholas J Vogelzang; Kah Poh Loh Journal: Oncologist Date: 2021-08-11